BioNTech SE: Lackluster Financials And Uncertainties In Product Pipeline-Hold
We rate BioNTech SE a hold due to volatile performance, weak growth, and premium valuation amidst COVID-19 vaccine reliance.
来自MSN20 小时
New Additive Improves Lithium-Sulfur Battery Performance
Lithium-ion (Li-ion) batteries are an integral part of society, from cellphones and laptops to electric vehicles. While ...